Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries. Results from the Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATO

[1]  P. Serruys,et al.  Long-term luminal renarrowing after successful elective coronary angioplasty of total occlusions. A quantitative angiographic analysis. , 1995, Circulation.

[2]  D. Faxon.  Effect of high dose angiotensin-converting enzyme inhibition on restenosis: Final results of the MARCATOR study, a multicenter, double-blind, placebo-controlled trial of cilazapril , 1995 .

[3]  P. Serruys,et al.  Restenosis revisited: insights provided by quantitative coronary angiography. , 1993, American heart journal.

[4]  D. Baim,et al.  Defining coronary restenosis. Newer clinical and angiographic paradigms. , 1993, Circulation.

[5]  P. Serruys,et al.  Does the New Angiotensin Converting Enzyme Inhibitor Cilazapril Prevent Restenosis After Percutaneous Transluminal Coronary Angioplast?: Results of the MERCATOR Study A Multicenter, Randomized, Double‐Blind Placebo‐Controlled Trial , 1992 .

[6]  K. Bailey,et al.  Initial and Long‐term Outcome of 354 Patients After Coronary Balloon Angioplasty of Total Coronary Artery Occlusions , 1992, Circulation.

[7]  W. Weintraub,et al.  Percutaneous Transluminal Coronary Angioplasty of Chronic Total Occlusions: Primary Success, Restenosis, and Long‐term Clinical Follow‐up , 1992, Circulation.

[8]  M. Bell,et al.  Balloon angioplasty of chronic total coronary artery occlusions: what does it cost in radiation exposure, time, and materials? , 1992, Catheterization and cardiovascular diagnosis.

[9]  D. Hunt,et al.  Coronary angioplasty for chronic total occlusion reduces the need for subsequent coronary bypass surgery. , 1990, American heart journal.

[10]  G. Stone,et al.  Procedural outcome of angioplasty for total coronary artery occlusion: an analysis of 971 lesions in 905 patients. , 1990, Journal of the American College of Cardiology.

[11]  T. Ryan,et al.  Clinical competence in percutaneous transluminal coronary angioplasty. A statement for physicians from the ACP/ACC/AHA Task Force on Clinical Privileges in Cardiology. , 1990, Journal of the American College of Cardiology.

[12]  E. Topol,et al.  Risk factors, time course and treatment effect for restenosis after successful percutaneous transluminal coronary angioplasty of chronic total occlusion. , 1989, The American journal of cardiology.

[13]  W Rutishauser,et al.  Percutaneous transluminal coronary angioplasty for chronic total coronary arterial occlusion. , 1987, The American journal of cardiology.

[14]  G. Vetrovec,et al.  Early and late outcome of percutaneous transluminal coronary angioplasty for subacute and chronic total coronary occlusion. , 1986, American heart journal.

[15]  D. Kereiakes,et al.  Angioplasty in total coronary artery occlusion: experience in 76 consecutive patients. , 1985, Journal of the American College of Cardiology.

[16]  P. Serruys,et al.  Elective PTCA of totally occluded coronary arteries not associated with acute myocardial infarction; short-term and long-term results. , 1985, European heart journal.

[17]  D. Baim,et al.  Transluminal angioplasty of occluded coronary arteries: use of a movable guide wire system. , 1983, Circulation.